Physician profile
Brigitte Davis
NPI 1508488370
$661.21
in general payments reported to CMS, 2019-2025
13 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.64 · 2024: $268 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $124.47 | 2024 | Perclot |
| Astellas Pharma US INC | $105.41 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $99.17 | 2025 | |
| Ethicon US, LLC | $53.32 | 2025 | Stratafix, Ethicon, Vistaseal |
| Organon LLC | $52.48 | 2023-2024 | Jada System |
| Exeltis, USA INC. | $47.83 | 2024 | Slynd |
| Boston Scientific Corporation | $45.28 | 2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Hologic Sales and Service, LLC | $34.44 | 2025 | Aptima, Novasure |
| Minerva Surgical, INC | $29.22 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $21.31 | 2025 | Gemtesa |
| Sage Therapeutics, LLC | $18.60 | 2025 | Zurzuvae |
| Novo Nordisk INC | $17.76 | 2025 | Wegovy |
| Intuitive Surgical, INC. | $11.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brigitte Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.